Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FlowCardia's VP wire and sheath:

This article was originally published in Clinica

Executive Summary

Representing its US market debut, FlowCardia has received US FDA 510(k) clearance for its VP wire and VP sheath products for facilitating the introduction and navigation of balloon catheters and other interventional devices in angioplasty procedures. The Sunnyvale, California firm also said that it was making progress in a US trial of its Crosser device for recanalising vessels with a chronic total occlusion (CTO). Over 80 of the required 125 patients have been enrolled in the pivotal phase of the study, called FACTOR. FlowCardia said it hoped to obtain FDA clearance for the product before the end of 2006.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050583

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel